Is it safe to use antidepressants after a stroke? (Q36235515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Is it safe to use antidepressants after a stroke? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Liborio Rampello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Giuseppe Battaglia

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rocco Raffaele

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Alessandro Alvano

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

885-897

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

Neuropsychiatric consequences of stroke

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depression after stroke and lesion location: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Relation of Lesion Location to Verbal and Nonverbal Mood Measures in Stroke Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Relation between depression after stroke, antidepressant therapy, and functional recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Relationship between depression, anxiety and quality of life: a study of stroke patients compared to chronic low back pain and myocardial ischemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Quality of life after stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depression after stroke: results of the FINNSTROKE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Treatment of uncontrolled crying after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

21 January 2018

Post-stroke depression

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Pharmacologic treatment of poststroke depression: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Fluoxetine in medically stable, depressed geriatric patients: effects on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Antidepressant therapy after stroke. A double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Venlafaxine- and trazodone-induced serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Interaction between warfarin and trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Possible therapeutic effect of T-794, a novel reversible inhibitor of monoamine oxidase-A, on post-stroke emotional disturbances, assessed in animal models of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Hypericin--the facts about a controversial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

SSRI treatment-associated stroke: causality assessment in two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Intracranial haemorrhage and use of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Selective serotonin reuptake inhibitors and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depressive symptoms and increased risk of stroke mortality over a 29-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depression as a contributing factor in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Venous thromboembolism and escitalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Depression and the Course of Coronary Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Mortality and poststroke depression: a placebo-controlled trial of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Cerebrovascular diseases and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

Pharmakotherapie der Altersdepression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.5.885

21 January 2018

Identifiers

DOI

10.1517/14740338.4.5.885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16111451%20AND%20SRC:MED&resulttype=core&format=json